ACM
IFRX icon

Altium Capital Management’s InflaRx IFRX Stock Holding History

Altium Capital Management’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-161,206
Closed -$479K – 139
2021
Q2 		$479K Sell
161,206
-613,394
-79% -$2.03M 0.11% 121
2021
Q1 		$3.02M Buy
+774,600
New +$3.97M 0.84% 48

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Altium Capital Management's IFRX Position: Q3 2021 in Review

Altium Capital Management sold out of InflaRx (IFRX) in Q3 2021, closing a stake of 161,206 shares — an estimated $479K sold.

Altium Capital Management first reported a position in IFRX in Q1 2021 and held it in 2 quarters. The position peaked at $3.02M in Q1 2021. 35 funds tracked by Wall St. Rank hold IFRX as of Q3 2021.

  • Altium Capital Management reported no remaining InflaRx position as of Q3 2021 after selling out during the quarter.
  • Altium Capital Management sold 161,206 InflaRx shares in Q3 2021, an estimated $479K.
  • Altium Capital Management first reported a position in InflaRx in Q1 2021 and held it in 2 quarters.
  • Altium Capital Management's InflaRx position peaked at $3.02M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q3 2021.

Based on Altium Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.